Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hurst

Showing results (181-190 of 641) with videos related to

Pageof 65
Sort By:
Thorax|July 2, 2003
Oesophagopleural fistula as a novel cause of failed non-invasive ventilationJ R Hurst, M I Polkey, P Goldstraw, et al.
Science (New York, N.Y.)|January 8, 1982
Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individualsJ Goldstein, G Siviglia, R Hurst, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|April 29, 2026
Rural <i>versus</i> urban living and COPD: a systematic reviewSamit Patel, Joseph Marchant, Surya P Bhatt, et al.
Journal of Public Health Management and Practice : JPHMP|February 8, 2000
Evaluating cardiovascular disease prevention programs in African American communitiesC A Pratt, R Hurst, K P Williams, et al.
The New England Journal of Medicine|November 25, 2011
Reduced lung-cancer mortality with CT screeningAnant R C Patel, Jadwiga A Wedzicha, John R Hurst
Respiratory Research|May 3, 2018
Pollution and respiratory disease: can diet or supplements help? A reviewT Whyand, J R Hurst, M Beckles, et al.
Transfusion|March 1, 1994
Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group OL L Lenny, R Hurst, J Goldstein, et al.
Eye (London, England)|June 14, 2008
UK national survey of current practice and experience of intravitreal triamcinolone acetonideS Jain, J R Hurst, J R Thompson, et al.
The European Respiratory Journal|August 21, 2025
A Cure for Alpha-1? Novel Therapeutics in Alpha-1 Antitrypsin DeficiencyReem Alluhibi, Aileen Marshall, David A Lomas, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 10, 2021
Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare ProfessionalsDave Singh, Steve Holmes, Claire Adams, et al.
Pageof 65

Showing results (181-190 of 641) with videos related to

Sort By:
Pageof 65
Thorax|July 2, 2003
Oesophagopleural fistula as a novel cause of failed non-invasive ventilationJ R Hurst, M I Polkey, P Goldstraw, et al.
Science (New York, N.Y.)|January 8, 1982
Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individualsJ Goldstein, G Siviglia, R Hurst, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|April 29, 2026
Rural <i>versus</i> urban living and COPD: a systematic reviewSamit Patel, Joseph Marchant, Surya P Bhatt, et al.
Journal of Public Health Management and Practice : JPHMP|February 8, 2000
Evaluating cardiovascular disease prevention programs in African American communitiesC A Pratt, R Hurst, K P Williams, et al.
The New England Journal of Medicine|November 25, 2011
Reduced lung-cancer mortality with CT screeningAnant R C Patel, Jadwiga A Wedzicha, John R Hurst
Respiratory Research|May 3, 2018
Pollution and respiratory disease: can diet or supplements help? A reviewT Whyand, J R Hurst, M Beckles, et al.
Transfusion|March 1, 1994
Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group OL L Lenny, R Hurst, J Goldstein, et al.
Eye (London, England)|June 14, 2008
UK national survey of current practice and experience of intravitreal triamcinolone acetonideS Jain, J R Hurst, J R Thompson, et al.
The European Respiratory Journal|August 21, 2025
A Cure for Alpha-1? Novel Therapeutics in Alpha-1 Antitrypsin DeficiencyReem Alluhibi, Aileen Marshall, David A Lomas, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 10, 2021
Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare ProfessionalsDave Singh, Steve Holmes, Claire Adams, et al.
Pageof 65